Proskauer, A&O Advise on Novartis' $1.7 Billion Diagnostics Sale

, The Am Law Daily

   |0 Comments

Swiss pharmaceutical giant Novartis has agreed to sell its blood transfusion diagnostics unit to Barcelona-based health care company Grifols for roughly $1.7 billion in cash. Allen & Overy is advising Novartis on the deal, while Proskauer and U.K. firm Osborne Clarke are representing Grifols.

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202627316310

Thank you!

This article's comments will be reviewed.